Skip to main content

Marqeta, Inc.

For the period ended Mar 31, 2026. Filed May 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

MQ$18.34-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Three Months Ended March 31,
20262025
Cash flows from operating activities:
Net income (loss)$7,834$(8,260)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation and amortization8,8545,331
Share-based compensation expense20,01725,915
Non-cash operating leases expense769535
Accretion of discount on short-term investments(34)(396)
Other(671)364
Changes in operating assets and liabilities:
Accounts receivable(4,631)1,312
Network incentives receivable(18,810)1,836
Settlements receivable(14,418)1,795
Prepaid expenses and other assets(1,531)(2,543)
Accounts payable(1,058)1,023
Revenue share payable35,61816,016
Accrued expenses and other liabilities(34,115)(31,837)
Operating lease liabilities(1,191)(1,104)
Net cash (used in) provided by operating activities(3,367)9,987
Cash flows from investing activities:
Maturities of short-term investments25,13422,186
Capitalization of internal-use software(7,798)(6,059)
Purchases of property and equipment(1,279)(1,266)
Net cash provided by investing activities16,05714,861
Cash flows from financing activities:
Repurchase of common stock(39,207)(111,310)
Change in funds payable and amounts due to customers(26,593)—
Taxes paid related to net share settlement of restricted stock units(8,789)(7,101)
Proceeds from exercise of stock options, including early exercised stock options, net of repurchase of early exercised unvested options511,444
Net cash used in financing activities(74,538)(116,967)
Net decrease in cash, cash equivalents, and restricted cash(61,848)(92,119)
Cash, cash equivalents, and restricted cash- Beginning of period1,017,931931,516
Cash, cash equivalents, and restricted cash - End of period$956,083$839,397

Condensed Consolidated Statements of Cash Flows

Three Months Ended March 31,
20262025
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents$674,790$830,897
Restricted cash280,3988,500
Restricted cash, included in Other assets895—
Total cash, cash equivalents, and restricted cash$956,083$839,397
Supplemental disclosures of non-cash investing and financing activities:
Contingent and holdback considerations, not yet paid$5,026$—
Repurchase of common stock, including excise tax, accrued and not yet paid$3,874$1,006
Share-based compensation capitalized to internal-use software$2,606$2,522
Purchase of property and equipment accrued and not yet paid$87$1,142
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.